In the ninth episode, Nicholas and Lana unpack several longevity launches making waves, and why regulatory clearance, novelty, and clinical data are 3 separate things brands shouldn't blur together.

A randomized, crossover trial found that ThymoDream, a standardized black cumin seed oil, raised endogenous melatonin levels and improved several sleep measures over 7 nights, with lower reported daytime sleepiness than synthetic melatonin.

Piping Rock Health Products has launched a 300-mg NMN gummy under its Vitafusion brand, arriving less than a year after the FDA reversed its position on whether the ingredient could legally be sold as a dietary supplement.

The Indian branded-ingredient supplier has closed a growth investment from NDude Labs to expand clinical research and establish a dedicated US commercial operation, reflecting investor interest in ingredient companies that lead with published data.

A mixed cell-culture and mouse study found that Ahiflower oil, a plant-based omega-3 source, reduced markers of endothelial inflammation, blood lipids, and platelet clotting activity at levels comparable to fish oil.

Pooled RCT evidence from three EU consortia shows non-nutritive sweeteners may support weight loss maintenance without adverse effects on biomarkers or taste preference.

A laboratory study using human liver cells found that Optifolin+, a choline-enriched form of 5-methyltetrahydrofolate, increased methyl-donor metabolite levels, adding cell-based data to the folate ingredient's evidence base ahead of any human methylation research.

Live from the Future Nutra Innovation Summit, Amber Thelen, director of technical services and innovation at Purity-IQ discusses strain-level verification gaps, NMR testing, and viability PCR for probiotic testing.